GMO, founded in 1977, is a privately held global investment management firm servicing clients that comprise corporate, public, endowment, foundation, financial intermediaries and family offices. We manage client assets using a blend of traditional judgments with innovative quantitative methods to find undervalued securities and markets.
Our success in consistently providing value added performance across a broad range of asset classes is founded on several key factors that include: discipline, value orientation, investment research and constant innovation. Our broad-based valued added over benchmarks has led many of our clients to request that we allocate assets and advise them on a global scale.
We serve our global client base from our headquarters in Boston and offices in San Francisco, London, Amsterdam, Singapore and Sydney.
Products & services:
- • Asset Management
The latest articles from GMO
Evaluating the Covid-19 Pandemic Risks & Resilience in the World’s Emerging Markets How are emerging market economies placed to cope with the current and anticipated fallout from the Covid-19 pandemic? Boston-headquartered GMO has introduced a disciplined and proprietary assessment and comparison framework to help assess the impact. Amit Bhartia, Portfolio Manager for GMO’s Emergin...
The latest thought leadership from GMO
Are Excess Optimism and Overconfidence Driving Glo...The Conrad Hotel in Bangkok was the venue for an animated discussion on global capital markets hosted by Boston-based US funds group GMO. The gathering of distinguished market practitioners and GMO portfolio managers mulled over a variety of fascinating topics. Can investors make money in long-only...
The latest events from GMO